GPRO GoPro Inc

SAN DIEGO, Nov. 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, December 3, 2009, at 9 a.m. Eastern Time (ET). The event will feature presentations on Gen-Probe's current business and future growth strategies by several Company executives. The meeting and webcast will conclude at noon ET. The meeting will be webcast live and may be accessed on the investors section of the Company's web site at http://www.gen-probe.com/. An archived version of the webcast will be available on the same web site for at least 30 days. About Gen-Probe Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Caution Regarding Forward-Looking Statements Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended September 30, 2009, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events. Contact: Paula Izidoro Investor Relations 858-410-8904 DATASOURCE: Gen-Probe Incorporated CONTACT: Paula Izidoro, Investor Relations of Gen-Probe Incorporated, +1-858-410-8904 Web Site: http://www.gen-probe.com/

Copyright